Is AbbVie a good stock to buy now?
Third, AbbVie is an excellent stock for dividend-seeking investors. The company offers a juicy yield of 3.67%– which is much higher than the S&P 500’s yield of 1.37%.
Who owns the most AbbVie stock?
The Vanguard Group, Inc.
Top 10 Owners of Abbvie Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 8.10% | 143,174,121 |
| BlackRock Fund Advisors | 4.57% | 80,720,669 |
| SSgA Funds Management, Inc. | 4.42% | 78,038,196 |
| JPMorgan Investment Management, I… | 2.17% | 38,257,284 |
Who are AbbVie’s customers?
AbbVie’s products are generally sold worldwide directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from AbbVie-owned distribution centers and public warehouses.
Is ABBV undervalued?
Next, AbbVie stock was notably undervalued. Finally, AbbVie stock also provided a high dividend yield, with regular dividend increases — AbbVie is one of just 66 Dividend Aristocrats, and one of just 40 Dividend Kings.
Is AbbVie a buy or hold?
Consensus Rating. AbbVie has received a consensus rating of Buy. The company’s average rating score is 2.56, and is based on 10 buy ratings, 5 hold ratings, and 1 sell rating.
What is the target price for AbbVie stock?
Stock Price Targets
| High | $200.00 |
|---|---|
| Median | $160.00 |
| Low | $135.00 |
| Average | $163.81 |
| Current Price | $152.00 |
Is AbbVie a Buy Sell or Hold?
Shares are consolidating with a buy point at 176.01, according to MarketSmith.com. AbbVie stock has an IBD Digital Composite Rating of 95 out of a best-possible 99. The CR measures a stock’s key growth metrics. So, its shares outrank 95% of all stocks in terms of technical and fundamental measures.
Why is AbbVie stock falling?
In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key drugs missed Wall Street estimates.
Does AbbVie pay well?
Based on our analysis, the employees in Business Development earn salaries at AbbVie that are well above average, with yearly earnings averaging $128,960. Employees working in the Sales department earn a relatively high salary as well, averaging $119,545 per year.
Is AbbVie Big pharma?
Innovation-driven AbbVie is the third largest pharma company by revenue this year.
What is the outlook for AbbVie?
The 22 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 168.75, with a high estimate of 200.00 and a low estimate of 135.00. The median estimate represents a +12.50% increase from the last price of 150.00.
Is AbbVie a good long term buy?
Summary. AbbVie has reported solid quarterly results, with no major surprises. The company’s Humira patent expiry in the US is an upcoming headwind but should be manageable. Thanks to a high dividend yield, not a lot of growth is required for AbbVie to be a good long-term investment.
Where is AbbVie in 5 years?
With a 5-year investment, the revenue is expected to be around +95.95%. Your current $100 investment may be up to $195.95 in 2027. Get It Now! Get Our PREMIUM Forecast Now, from ONLY $8.49!
How much do AbbVie directors make?
The typical AbbVie Director salary is $217,028 per year. Director salaries at AbbVie can range from $117,863 – $301,040 per year. This estimate is based upon 102 AbbVie Director salary report(s) provided by employees or estimated based upon statistical methods.
What are the job levels at AbbVie?
Abbvie, Inc Jobs by Salary
| Job Title | Range | Average |
|---|---|---|
| Associate Research Scientist | Range:$55k – $96k | Average:$72,496 |
| Senior Financial Analyst | Range:$79k – $121k | Average:$98,967 |
| Clinical Research Associate (CRA) | Range:$54k – $112k | Average:$78,546 |
| Research Scientist, Biotechnology | Range:$52k – $117k | Average:$79,589 |